SCH 420814

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCH 420814, covering 2016-12-06 to 2016-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) [Phase 2]